查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1375903

诱导性多功能干细胞（iPS 细胞）生产市场规模、份额和趋势分析报告：按工艺、按工作流程、按产品、按应用、按最终用途、按地区和细分趋势，2023-2030 年

Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10个工作天内

价格

诱导性多功能干细胞（iPS 细胞）生产市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，预计到2030年，全球诱导性多功能干细胞生产市场规模将达到27.6亿美元。

预计2023年至2030年该市场将以9.3%的年复合成长率扩张。与诱导性多功能干细胞）的需求不断增长，显着推动了市场的发展。干细胞不存在伦理问题、个体化治疗的可能性以及细胞研究的弹性等优势为市场成长创造了有利的前景。此外，慢性病的流行也推动了诱导性多功能干细胞生产市场的成长。这是因为心臟病、中风、糖尿病和许多其他疾病都可以使用 iPS 细胞介导的疗法来治疗。例如，根据国际糖尿病联盟 (IDF) 的数据，到 2021 年，将有 5.37 亿人患有糖尿病。

COVID-19 大流行期间研究活动的增加对市场产生了积极影响。由于 SARS CoV-2 感染已导致患者患有多种疾病，因此这次疫情大流行刺激了许多领域的研究。例如，2021年4月，美国研究人员表示，高达25%的COVID-19患者患有心臟功能障碍。透过他们的研究论文，他们证明了 SARS CoV-2 是由将 iPS 细胞衍生的心臟细胞暴露于 SARS CoV-2 引起的，并且在患者的人体尸检标本中也证实了类似的变化。这些见解使得能够使用诱导性多功能干细胞(iPSC) 作为开发药物和治疗方法的平台，以控制 COVID-19 的长期影响。

诱导诱导性多功能干细胞是源自成体细胞的细胞，并进一步重新编程以获得类似 ESC 的多功能。事实证明，这些 iPS 细胞对于使用 ESC 进行研究来说是一个在伦理上合理的选择。伦理争议最激烈，因为胚胎干细胞的产生涉及破坏胚囊阶段的胚胎。然而，诱导性多功能干细胞仅透过对体细胞进行基因重编程，就解决了研究中破坏人类胚胎的伦理问题。这推动了市场成长，并带来了药物研发、疾病建模和毒性测试等众多应用。例如，2021年8月，Fate Therapeutics宣布临床试验中首例FT819患者接受治疗。 FT819是一种源自iPS细胞的人工CAR-T细胞疗法。由于其独特的特性，如可再生潜力和免疫调节特性，研究界越来越关注探索诱导性多功能干细胞在再生医学中的应用，从而推动了市场的扩张。

诱导性多功能干细胞生产市场报告亮点

  • 从製程来看，手动iPSC製造流程占据市场主导地位，2022年占最大销售份额，为77.2%。
  • 从工作流程来看，细胞培养部门在市场中占据主导地位，2022 年占销售额的最大份额为 37.3%。细胞培养工作流程包括来自 iPSC 收穫产品、扩增产品和分化产品的收益，有助于提高该细分市场的市场相关性。
  • 按产品划分，消耗品和套件细分市场占据主导地位，2022 年占据最大销售份额，达到 40.3%。 iPSC 领域的持续研发活动正在推动对各种消耗品和试剂盒的需求。
  • 按应用划分，药物研发与发现领域占最大销售份额，2022年为43.3%。
  • 按最终用途划分，生物技术和製药公司细分市场占据主导地位，2022 年收益占有率最高，达 59.3%。各种试剂盒、消耗品和仪器以及 iPSC 产品的可用性和采用正在推动该领域的产生收入。
  • 北美地区主导市场，2022 年收益占有率最大，达 40.8%。该地区慢性病患病率不断上升、医疗基础设施发达、公共和私人项目的资金以及战略商业模式正在推动市场产生收入。

目录

第1章调查方法与范围

第2章执行摘要

第3章诱导性多功能干细胞生产市场变数、趋势与范围

  • 市场体系展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 诱导性多功能干细胞生产市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章诱导性多功能干细胞的製造：依製程进行的估算与趋势分析

  • 诱导性多功能干细胞生产市场：重点
  • 诱导性多功能干细胞生产市场：2022 年和 2030 年趋势和市场占有率分析
  • 手动 iPSC 生产流程
    • 2018 年至 2030 年手动 iPSC 生产製程市场估计与预测
  • 自动化 iPSC 生产流程
    • 2018年至2030年自动化iPSC生产流程市场估计与预测

第5章诱导性多功能干细胞的製造：透过工作流程进行估算与趋势分析

  • 诱导性多功能干细胞生产市场：重点
  • 诱导性多功能干细胞生产市场：2022 年和 2030 年趋势和市场占有率分析
  • 重新程式设计
  • 细胞培养
  • 细胞表征/分析
  • 工程
  • 其他的

第6章诱导性多功能干细胞的生产：依产品估算与趋势分析

  • 诱导性多功能干细胞生产市场：重点
  • 诱导性多功能干细胞生产市场：2022 年和 2030 年趋势和市场占有率分析
  • 设备/设备
    • 2018年至2030年设备及设备市场预测
  • 自动化平台
    • 2018年至2030年自动化平台市场预测
  • 消耗品/套件
    • 2018 年至 2030 年消耗品和套件的市场估计和预测
    • 培养基
    • 成套工具
    • 其他的
  • 服务
    • 2018年至2030年服务市场估计与预测

第7章诱导性多功能干细胞的产生：应用的估计和趋势分析

  • 诱导性多功能干细胞生产市场：重点
  • 诱导性多功能干细胞生产市场：2022 年和 2030 年趋势和市场占有率分析
  • 药物研发/发现
  • 再生医学
  • 毒理学研究
  • 其他的

第8章诱导性多功能干细胞的生产：最终用途的估计和趋势分析

  • 诱导性多功能干细胞生产市场：重点
  • 诱导性多功能干细胞生产市场：2022 年和 2030 年趋势和市场占有率分析
  • 研究/学术机构
    • 2018年至2030年研究和学术机构的市场估计和预测
  • 生物技术和製药公司
    • 2018年至2030年生物技术和製药公司的市场估计和预测
  • 医院/诊所
    • 2018 年至 2030 年医院和诊所的市场估计和预测

第9章诱导性多功能干细胞的生产：各地区的估算与趋势分析

  • 区域展望
  • 按地区分類的诱导性多功能干细胞生产市场：关键市场点
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第10章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Lonza
    • Axol Biosciences Ltd.
    • Evotec Se
    • Hitachi Ltd.
    • Reprocells Inc.
    • Fate Therapeutics
    • Thermo Fisher Scientific, Inc.
    • Merck Kgaa
    • StemCellsFactory III
    • Applied StemCells, Inc.
Product Code: GVR-4-68039-549-7

Induced Pluripotent Stem Cells Production Market Growth & Trends:

The global induced pluripotent stem cells production market size is estimated to reach USD 2.76 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 9.3% from 2023 to 2030. The increase in demand for induced pluripotent stem cells (iPSCs) in comparison to Embryonic Stem Cells (ESCs) has offered a significant drive to the market. Advantages such as no stem cell-related ethical issues, personalized treatment, and flexibility during cell-based research have created a favorable scenario for market growth. In addition, the prevalence of chronic disorders is also driving the growth of the induced pluripotent stem cells production market, as conditions like heart disease, stroke, diabetes, and many more can be treated by utilizing iPSCs-mediated therapy. For example, according to the International Diabetes Federation (IDF), 537 million people are already living with diabetes in 2021.

The rising research activities during COVID-19 pandemic have positively impacted the market. The pandemic fueled research in many fields as the SARS CoV-2 infection resulted in many diseases in the patients. For instance, in April 2021, researchers from USA stated that up to 25% of COVID-19 patients suffered cardiac dysfunction. Through their research article, they demonstrated the pathogenesis via exposure of iPSCs-derived cardiac cells to SARS CoV-2, and similar alterations were confirmed from human autopsy specimens of the patients. Such insights allow the use of induced pluripotent stem cells (iPSCs) as drug or therapy development platforms and their utilization in the management of the long-term effects of COVID-19.

Induced pluripotent stem cells are cells that are derived from adult somatic cells and then further reprogrammed to obtain the pluripotency as that of ESCs. These iPSCs are proving to be an ethically uncomplicated alternative for research that involves ESCs. The derivation of the ESCs is associated with the destruction of an embryo at the blastocyte stage, which has led to a maximum number of ethical debates. However, induced pluripotent stem cells have solved the ethical issue over the destruction of human embryos in research by involving only the genetic reprogramming of somatic cells. This has propelled the market growth and resulted in numerous applications including drug discovery, disease modeling, toxicology testing, and many others. For instance, in August 2021, Fate Therapeutics announced the treatment of the first patient with FT819 during clinical trials. FT819 is an engineered CAR-T cell therapy that is derived from iPSCs. Also, the rising focus of the research community on exploring applications of induced pluripotent stem cells in regenerative medicine due to their unique characteristics such as differential potential, self-renewable, immunomodulatory properties, and others; is set to drive the market expansion.

Induced Pluripotent Stem Cells Production Market Report Highlights:

  • By process, the manual iPSC production process segment dominated the market and accounted for the largest revenue share of 77.2% in 2022.
  • By workflow, the cell culture segment dominated the market with the largest revenue share of 37.3% in 2022. Cell culture workflow is inclusive of revenues generated from iPSC harvest products, expansion products, and differentiation products; thus contributing to the market relevance of this segment.
  • By product, the consumables and kits segment dominated the market and accounted for the largest revenue share of 40.3% in 2022. The never-ceasing research and development activities in the iPSCs space are driving the demand for various consumables & kits.
  • By application, drug development & discovery segment dominated the market with the largest revenue share of 43.3% in 2022.
  • By end-user, the biotechnology and pharmaceutical companies segment dominated the market with the largest revenue share of 59.3% in 2022. The availability and adoption of various kits, consumables, and instruments along with iPSCs products are driving the revenue generation in this segment.
  • North America dominated the market and accounted for the largest revenue share of 40.8% in 2022. The growing incidence of chronic diseases in this region, developed healthcare infrastructure, funds from private & government initiatives, and strategic business models are driving the revenue generation in the marketspace.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Process
    • 1.1.2. Workflow
    • 1.1.3. Product
    • 1.1.4. Application
    • 1.1.5. End use
    • 1.1.6. Regional scope
    • 1.1.7. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Process outlook
    • 2.2.2. Workflow outlook
    • 2.2.3. Product outlook
    • 2.2.4. Application outlook
    • 2.2.5. End use outlook
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Induced Pluripotent Stem Cells Production Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Induced Pluripotent Stem Cells Production Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Induced Pluripotent Stem Cells Production: Process Estimates & Trend Analysis

  • 4.1. Induced Pluripotent Stem Cells Production Market: Key Takeaways
  • 4.2. Induced Pluripotent Stem Cells Production Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Manual iPSC Production Process
    • 4.3.1. Manual iPSC production process market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Automated iPSC Production Process
    • 4.4.1. Automated iPSC production process market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Induced Pluripotent Stem Cells Production: Workflow Estimates & Trend Analysis

  • 5.1. Induced Pluripotent Stem Cells Production Market: Key Takeaways
  • 5.2. Induced Pluripotent Stem Cells Production Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Reprogramming
    • 5.3.1. Reprogramming market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Cell Culture
    • 5.4.1. Cell culture market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Cell Characterization / Analysis
    • 5.5.1. Cell characterization / analysis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Engineering
    • 5.6.1. Engineering market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Induced Pluripotent Stem Cells Production: Product Estimates & Trend Analysis

  • 6.1. Induced Pluripotent Stem Cells Production Market: Key Takeaways
  • 6.2. Induced Pluripotent Stem Cells Production Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Instruments/ Devices
    • 6.3.1. Instruments/ devices market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Automated Platforms
    • 6.4.1. Automated platforms market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Consumables & Kits
    • 6.5.1. Consumables & kits market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.2. Media
      • 6.5.2.1. Media market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.3. Kits
      • 6.5.3.1. Kits market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.4. Others
      • 6.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Services
    • 6.6.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Induced Pluripotent Stem Cells Production: Application Estimates & Trend Analysis

  • 7.1. Induced Pluripotent Stem Cells Production Market: Key Takeaways
  • 7.2. Induced Pluripotent Stem Cells Production Market: Movement & Market Share Analysis, 2022 & 2030
  • 7.3. Drug Development & Discovery
    • 7.3.1. Drug development & discovery market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Regenerative Medicine
    • 7.4.1. Regenerative medicine market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Toxicology Studies
    • 7.5.1. Toxicology studies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Induced Pluripotent Stem Cells Production: End Use Estimates & Trend Analysis

  • 8.1. Induced Pluripotent Stem Cells Production Market: Key Takeaways
  • 8.2. Induced Pluripotent Stem Cells Production Market: Movement & Market Share Analysis, 2022 & 2030
  • 8.3. Research & Academic Institutes
    • 8.3.1. Research & academic institutes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4. Biotechnology & Pharmaceutical Companies
    • 8.4.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5. Hospitals & Clinics
    • 8.5.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Induced Pluripotent Stem Cells Production: Regional Estimates & Trend Analysis

  • 9.1. Regional Outlook
  • 9.2. Induced Pluripotent Stem Cells Production Market by Region: Key Marketplace Takeaway
  • 9.3. North America
    • 9.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.4. Europe
    • 9.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.2. UK
      • 9.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.4. France
      • 9.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.7. Sweden
      • 9.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.8. Norway
      • 9.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.9. Denmark
      • 9.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.3. China
      • 9.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.4. India
      • 9.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.5. Australia
      • 9.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.7. South Korea
      • 9.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.6.3. Mexico
      • 9.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.6.4. Argentina
      • 9.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.7. MEA
    • 9.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.7.3. South Africa
      • 9.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Market Participant Categorization
    • 10.2.1. Lonza
      • 10.2.1.1. Company overview
      • 10.2.1.2. Financial performance
      • 10.2.1.3. Product benchmarking
      • 10.2.1.4. Strategic initiatives
    • 10.2.2. Axol Biosciences Ltd.
      • 10.2.2.1. Company overview
      • 10.2.2.2. Financial performance
      • 10.2.2.3. Product benchmarking
      • 10.2.2.4. Strategic initiatives
    • 10.2.3. Evotec Se
      • 10.2.3.1. Company overview
      • 10.2.3.2. Financial performance
      • 10.2.3.3. Product benchmarking
      • 10.2.3.4. Strategic initiatives
    • 10.2.4. Hitachi Ltd.
      • 10.2.4.1. Company overview
      • 10.2.4.2. Financial performance
      • 10.2.4.3. Product benchmarking
      • 10.2.4.4. Strategic initiatives
    • 10.2.5. Reprocells Inc.
      • 10.2.5.1. Company overview
      • 10.2.5.2. Financial performance
      • 10.2.5.3. Product benchmarking
      • 10.2.5.4. Strategic initiatives
    • 10.2.6. Fate Therapeutics
      • 10.2.6.1. Company overview
      • 10.2.6.2. Financial performance
      • 10.2.6.3. Product benchmarking
      • 10.2.6.4. Strategic initiatives
    • 10.2.7. Thermo Fisher Scientific, Inc.
      • 10.2.7.1. Company overview
      • 10.2.7.2. Financial performance
      • 10.2.7.3. Product benchmarking
      • 10.2.7.4. Strategic initiatives
    • 10.2.8. Merck Kgaa
      • 10.2.8.1. Company overview
      • 10.2.8.2. Financial performance
      • 10.2.8.3. Product benchmarking
      • 10.2.8.4. Strategic initiatives
    • 10.2.9. StemCellsFactory III
      • 10.2.9.1. Company overview
      • 10.2.9.2. Financial performance
      • 10.2.9.3. Product benchmarking
      • 10.2.9.4. Strategic initiatives
    • 10.2.10. Applied StemCells, Inc.
      • 10.2.10.1. Company overview
      • 10.2.10.2. Financial performance
      • 10.2.10.3. Product benchmarking
      • 10.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 3 North America induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 4 North America induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America induced pluripotent stem cells production market, by region, 2018 - 2030 (USD Million)
  • Table 8 U.S. induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 9 U.S. induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 10 U.S. induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 14 Canada induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 15 Canada induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 16 Canada induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 17 Canada induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Europe induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 19 Europe induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 20 Europe induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Europe induced pluripotent stem cells production market, by region, 2018 - 2030 (USD Million)
  • Table 24 Germany induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 25 Germany induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 26 Germany induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 27 Germany induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 29 UK induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 30 UK induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 31 UK induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 32 UK induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 33 UK induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 34 France induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 35 France induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 36 France induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 37 France induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 38 France induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Italy induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 40 Italy induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 41 Italy induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 42 Italy induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 43 Italy induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Spain induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 45 Spain induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 46 Spain induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 47 Spain induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 48 Spain induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Sweden induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 50 Sweden induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 51 Sweden induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 52 Sweden induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 53 Sweden induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Norway induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 55 Norway induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 56 Norway induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 57 Norway induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 58 Norway induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Norway induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 60 Denmark induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 61 Denmark induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 62 Denmark induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 63 Denmark induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 67 Asia Pacific induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 68 Asia Pacific induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific induced pluripotent stem cells production market, by region, 2018 - 2030 (USD Million)
  • Table 70 China induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 71 China induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 72 China induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 73 China induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 74 China induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Japan induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 76 Japan induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 77 Japan induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 78 Japan induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 79 Japan induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 80 India induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 81 India induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 82 India induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 83 India induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 84 India induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Australia induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 86 Australia induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 87 Australia induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 88 Australia induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 89 Australia induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Thailand induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 91 Thailand induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 92 Thailand induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 93 Thailand induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 94 Thailand induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 95 South Korea induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 96 South Korea induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 97 South Korea induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 98 South Korea induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 99 South Korea induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 100 Latin America induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 101 Latin America induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 102 Latin America induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 103 Latin America induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 104 Latin America induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 105 Latin America induced pluripotent stem cells production market, by region, 2018 - 2030 (USD Million)
  • Table 106 Brazil induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 107 Brazil induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 108 Brazil induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 109 Brazil induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 110 Brazil induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 111 Mexico induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 112 Mexico induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 113 Mexico induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 114 Mexico induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 115 Mexico induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 116 Argentina induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 117 Argentina induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 118 Argentina induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 119 Argentina induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 120 Argentina induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 121 Middle East and Africa induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 122 Middle East and Africa induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 123 Middle East and Africa induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 124 Middle East and Africa induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 125 Middle East and Africa induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 126 Middle East and Africa induced pluripotent stem cells production market, by region, 2018 - 2030 (USD Million)
  • Table 127 South Africa induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 128 South Africa induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 129 South Africa induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 130 South Africa induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 131 South Africa induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 132 Saudi Arabia induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 137 UAE induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 138 UAE induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 139 UAE induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 140 UAE induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 141 UAE induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 142 Kuwait induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 143 Kuwait induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 144 Kuwait induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 145 Kuwait induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 146 Kuwait induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Induced pluripotent stem cells production: Market outlook
  • Fig. 8 Induced pluripotent stem cells production: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Induced pluripotent stem cells production market driver impact
  • Fig. 14 Induced pluripotent stem cells production market restraint impact
  • Fig. 15 Induced pluripotent stem cells production market strategic initiatives analysis
  • Fig. 16 Induced pluripotent stem cells production market: Process movement analysis
  • Fig. 17 Induced pluripotent stem cells production market: Process outlook and key takeaways
  • Fig. 18 Manual iPSC production process estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Automated iPSC production process estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Induced pluripotent stem cells production market: Workflow movement analysis
  • Fig. 21 Induced pluripotent stem cells production market: Workflow outlook and key takeaways
  • Fig. 22 Reprogramming market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Cell characterization / analysis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Induced pluripotent stem cells production market: Product movement analysis
  • Fig. 28 Induced pluripotent stem cells production market: Product outlook and key takeaways
  • Fig. 29 Instruments/ devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Automated platforms market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Consumables & kits market estimates and forecasts, 2018 - 2030
  • Fig. 32 Media market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Induced pluripotent stem cells production market: Application movement analysis
  • Fig. 37 Induced pluripotent stem cells production market: Application outlook and key takeaways
  • Fig. 38 Drug development and discovery market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Regenerative medicine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Toxicology studies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Others market estimates and forecasts, 2018 - 2030
  • Fig. 42 Induced pluripotent stem cells production market: End use movement analysis
  • Fig. 43 Induced pluripotent stem cells production market: End use outlook and key takeaways
  • Fig. 44 Research & academic institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Global Induced pluripotent stem cells production market: Regional movement analysis
  • Fig. 48 Global Induced pluripotent stem cells production market: Regional outlook and key takeaways
  • Fig. 49 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)